Skip to content

Ashland

US · ASH #2461 by market cap Listed 1970
70.67 -0.30 -0.42%
Live - 5344 symbols - heartbeat 76s ago · 2026-10-08 09:11
Pre-market 70.30 -0.52%
After-hours 70.67 0.00%
Market cap
3.24B
P/B
1.73
EPS
-18.23
Reader sentiment Are you bullish or bearish on ASH?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 1.74 Expensive vs history 82nd percentile
5-year average 1.50 · #27 of 56 in Specialty Chemicals
P/E ratio 67.59 Expensive vs history 98th percentile
5-year average 9.35 · forward 28.04 · #29 of 32 in Specialty Chemicals
P/S ratio 1.76 In line with history 37th percentile
5-year average 1.94 · forward 1.68 · #33 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Ashland (ASH) 3.24B 67.30 1.73 2.36%
Linde (LIN) 223.11B 31.22 5.71 1.28%
Ecolab (ECL) 77.96B 37.33 7.75 1.02%
Sherwin-Williams (SHW) 76.47B 29.06 19.84 1.01%
Air Products & Chemicals (APD) 61.93B -1,324.38 4.46 2.59%
PPG Industries (PPG) 23.36B 15.03 2.77 2.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★☆ Fair value78.41 Economic moatNone UncertaintyLow

Trading 10.9% below Morningstar's fair value estimate.

Fair value

Ashland Inc is assigned a 4-star quantitative star rating, illustrating our stance that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 12% discount to our quantitative fair value estimate of $78.41 per share, which is reinforced by this estimate's low uncertainty rating.

The company's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to market value ratio of 1.3, which ranks in the top 30% globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. We believe this is a sign that shares could be undervalued.

On a different note, the firm's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 3.2%, a core component of profitability, lies in the bottom 45% compared with global peers. The earnings generated by the company relative to its share price is concerning, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 09:11:03 · For reference only, not investment advice and not tailored to your situation.